Connective tissue diseases (CTDs) are a group of disorders characterized by abnormal immune system activity affecting the connective tissues throughout the body. These tissues include tendons, ligaments, skin, joints, and organs. Common CTDs include rheumatoid arthritis, systemic lupus erythematosus, and scleroderma. In CTDs, the immune system mistakenly attacks healthy tissues, leading to inflammation and tissue damage. Symptoms vary widely and may involve joint pain, skin rashes, fatigue, and internal organ complications. Treatment aims to manage symptoms and control inflammation, typically utilizing medications such as corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and immunosuppressants. Multidisciplinary care involving rheumatologists, dermatologists, and other specialists is crucial for comprehensive management. Early detection and intervention play a key role in improving outcomes and enhancing the quality of life for individuals affected by connective tissue diseases.
Title : The UK profemur recall and implant cobaltism
Stephen S Tower, University of Alaska Anchorage, United States
Title : The tomographic phenotype and the genotype of wormain bones
Ali Al Kaissi, National Ilizarov Medical Research Center for Traumatology and Orthopaedics, Russian Federation
Title : New treatment of muscle contracture and joint contracture through muscle regeneration with mitochondrial dynamics
Ki Ji Lee, Busan Medical University, Korea, Republic of
Title : New treatment of sarcopenia through muscle regeneration with mitochondrial dynamics
Ki Ji Lee, Busan Medical University, Korea, Republic of
Title : The prevalence and association of self-reported depression symptoms with musculoskeletal pain and quality of life among pregnant women
Youssef Masharawi, Tel Aviv University, Israel
Title : Bipolar hemiarthroplasty under local anesthesia (2%)
Ketan Karabhai Parmar, Aayush Multispecialty Hospital, India